You are here

empagliflozin

Lilly, BI-Partnered Kidney Trial Stopped Early Due to Positive Results

BioSpace

Wed, 03/16/22 - 11:20 pm

Boehringer Ingelheim

clinical trials

chronic kidney disease

FDA blocks Lilly, Boehringer's Jardiance from coveted Type 1 diabetes nod

Fierce Pharma

Mon, 03/23/20 - 11:54 am

Boehringer Ingelheim

type 1 diabetes

Eli Lilly/ Boehringer Drug Under FDA Review

Yahoo/Zacks.com

Tue, 04/15/14 - 04:49 pm

Boehringer Ingelheim

type 2 diabetes

What Does This Rejection Mean for Eli Lilly?

Motley Fool

Fri, 03/7/14 - 09:24 am

Boehringer Ingelheim

Lilly’s Diabetes Pill Rejected by FDA Over Manufacturing

Bloomberg

Wed, 03/5/14 - 11:44 am

Boehringer Ingelheim

Could These Potential Catalysts Drive Lilly Higher?

Motley Fool

Tue, 02/4/14 - 06:58 pm

Alzheimer's disease

Eli Lilly: 2014 Predictions

Seeking Alpha

Tue, 01/21/14 - 09:42 am

The Diabetes Pipeline With a Clog

Motley Fool

Mon, 07/22/13 - 06:02 pm

Bristol-Myers Squibb

SGLT2 inhibitor

Phase III data show significant reductions in blood glucose with investigational compound empagliflozin used as monotherapy in adults with type 2 diabetes

Yahoo/PR NewsWire

Sun, 06/23/13 - 11:20 am

type 2 diabetes

Boehringer Ingelheim

Pipeline Vs. Expiring Patents: Eli Lilly's Future

Seeking Alpha

Thu, 06/20/13 - 11:00 am

Eli Lilly's Big Bet On Diabetes

Seeking Alpha

Tue, 04/23/13 - 07:54 am

Eli Lilly Submits New Type 2 Diabetes Drug for FDA Review

Motley Fool

Tue, 03/26/13 - 09:20 am

Boehringer Ingelheim

Big News for These 2 Diabetes Hopefuls

Motley Fool

Mon, 01/7/13 - 06:52 pm

New Diabetes Drugs May Push Eli Lilly Higher By 2013

Seeking Alpha

Thu, 06/21/12 - 07:39 am

Bristol-Myers Squibb

Boehringer Ingelheim